SCHEMBL7344311

SCHEMBL7344311

CCOc1ccc(C2OC2C(=O)O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.54
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
KMT2A Q03164 2/20 0.46
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
MAPT P10636 1/20 0.46
NQO1 P15559 1/20 0.45
PARP10 Q53GL7 1/20 0.45
RELA Q04206 1/20 0.45
LTA4H P09960 1/20 0.44
ALDH1A1 P00352 1/20 0.44
PLA2G4B P0C869 1/20 0.44
POLB P06746 2/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 1/20 0.43
EGFR P00533 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7344315 1.00 TSHR (0.54) TSHRNPC1RAB9AKMT2AMAOA
SCHEMBL27029050 0.86 TSHR (0.47) TSHRKMT2AMAPK1SMN1; SMN2L3MBTL1
SCHEMBL27029056 0.86 TSHR (0.47) TSHRKMT2AMAPK1SMN1; SMN2L3MBTL1
SCHEMBL27029087 0.86 TSHR (0.47) TSHRKMT2AMAPK1SMN1; SMN2L3MBTL1
SCHEMBL27133236 0.86 TSHR (0.47) TSHRKMT2AMAPK1SMN1; SMN2L3MBTL1
SCHEMBL29097148 0.83 TSHR (0.45) TSHRMAPTALDH1A1PLA2G4BSMN1; SMN2
SCHEMBL7144597 0.83 EDNRA (0.54) TSHRNPC1RAB9AKMT2AMAOA
SCHEMBL7293698 0.83 EDNRA (0.54) TSHRNPC1RAB9AKMT2AMAOA
SCHEMBL9258771 0.83 EDNRA (0.54) TSHRNPC1RAB9AKMT2AMAOA
SCHEMBL6229779 0.83 EDNRA (0.54) TSHRNPC1RAB9AKMT2AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4808580-A Naphtho[1,2-b][1,4]thiazepin-4(5H)-ones and use thereof in treatment of ischemia and blood pressure lowering HOFFMANN-LA ROCHE INC. (US) 1989-02-28 US disclosed
EP-0239050-A1 2,3-Dihydro-2-phenyl-5-aminoalkyl-naphto ¬1,8-bc -1,5-thiazocin-4 (5H)-one derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-30 EP disclosed
EP-0234561-A2 2,3-Dihydro-2-phenyl-5-aminoalkyl-naphtho [1,2-b]-1,4-thiazepin-4(5H)-one derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-02 EP disclosed
US-4652561-A HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1987-03-24 US disclosed
US-4640930-A CALCIUM CHANNEL BLOCKERS HOFFMANN-LA ROCHE INC. (US) 1987-02-03 US disclosed